Literature DB >> 12743596

TMEFF1 and brain tumors.

Sigal Gery1, Dong Yin, Dong Xie, Keith L Black, H Phillip Koeffler.   

Abstract

TMEFF1 is a novel transmembrane protein, containing two follisatin domains and an epidermal growth factor-like region. These structural domains suggest a role for TMEFF1 in growth factor signaling. TMEFF1 fused to enhanced green fluorescent protein revealed that TMEFF1 is expressed on the cell membrane. Northern analysis of normal human tissue showed that TMEFF1 is predominantly expressed in the brain. Study of cancer cell lines from different tissues including the brain, demonstrated moderate to low levels of TMEFF1 in most of these transformed cell lines. Furthermore, quantitative real-time RT-PCR analysis of 54 brain tumors showed that most of these tumors (96%) had lower levels of TMEFF1 expression than normal brain tissue. Interestingly, ectopic expression of TMEFF1 in brain cancer cells resulted in their growth inhibition. These data suggest that TMEFF1 may behave as a tumor suppressor gene in brain cancers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743596     DOI: 10.1038/sj.onc.1206351

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis.

Authors:  Julien Laffaire; Sibille Everhard; Ahmed Idbaih; Emmanuelle Crinière; Yannick Marie; Aurelien de Reyniès; Renaud Schiappa; Karima Mokhtari; Khê Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Joëlle Thillet; François Ducray
Journal:  Neuro Oncol       Date:  2010-10-05       Impact factor: 12.300

2.  Butorphanol Inhibits the Malignant Biological Behaviors of Ovarian Cancer Cells via Down-Regulating the Expression of TMEFF1.

Authors:  Baosheng Wang; Yuwen Li; Yangyang Shen; Yong Xu; Chuanfeng Zhang
Journal:  Onco Targets Ther       Date:  2020-10-28       Impact factor: 4.147

3.  Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto.

Authors:  Paul W Harms; Chenbei Chang
Journal:  Genes Dev       Date:  2003-10-16       Impact factor: 11.361

4.  Analysis of TMEFF2 allografts and transgenic mouse models reveals roles in prostate regeneration and cancer.

Authors:  Joshua M Corbin; Ryan F Overcash; Jonathan D Wren; Anita Coburn; Greg J Tipton; Jennifer A Ezzell; Kirk K McNaughton; Kar-Ming Fung; Stanley D Kosanke; Maria J Ruiz-Echevarria
Journal:  Prostate       Date:  2015-09-29       Impact factor: 4.104

5.  Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma.

Authors:  Maud Condomines; Dirk Hose; Thierry Rème; Guilhem Requirand; Michael Hundemer; Matthieu Schoenhals; Hartmut Goldschmidt; Bernard Klein
Journal:  J Immunol       Date:  2009-06-19       Impact factor: 5.422

6.  Tomoregulin-1 prevents cardiac hypertrophy after pressure overload in mice by inhibiting TAK1-JNK pathways.

Authors:  Dan Bao; Dan Lu; Ning Liu; Wei Dong; Ying-Dong Lu; Chuan Qin; Lian-Feng Zhang
Journal:  Dis Model Mech       Date:  2015-06-18       Impact factor: 5.758

7.  TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer.

Authors:  Xin Nie; Cong Liu; Qian Guo; Ming-Jun Zheng; Ling-Ling Gao; Xiao Li; Da-Wo Liu; Lian-Cheng Zhu; Juan-Juan Liu; Bei Lin
Journal:  Cancer Manag Res       Date:  2019-01-17       Impact factor: 3.989

8.  A feature selection approach for identification of signature genes from SAGE data.

Authors:  Junior Barrera; Roberto M Cesar; Carlos Humes; David C Martins; Diogo F C Patrão; Paulo J S Silva; Helena Brentani
Journal:  BMC Bioinformatics       Date:  2007-05-22       Impact factor: 3.169

9.  Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells.

Authors:  Xin Nie; Lingling Gao; Mingjun Zheng; Caixia Wang; Shuang Wang; Xiao Li; Yue Qi; Liancheng Zhu; Juanjuan Liu; Bei Lin
Journal:  J Cancer       Date:  2021-07-31       Impact factor: 4.207

Review 10.  Opioids in cancer: The κ‑opioid receptor (Review).

Authors:  Qier Zhou; Zhiwei Zhang; Songkai Long; Wanjun Li; Baiyun Wang; Na Liang
Journal:  Mol Med Rep       Date:  2021-12-08       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.